Selecting an invertebrate model host for the study of fungal pathogenesis

PLoS Pathogens

Volumn 8, Issue 2, 2012, Pages

  Desalermos, Athanasios ^a   Fuchs, Beth Burgwyn ^a   Mylonakis, Eleftherios ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ASTEMIZOLE; FLUCONAZOLE; MEVINOLIN; VIRULENCE FACTOR;

ACANTHAMOEBA CASTELLANII; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BLASTOMYCES DERMATITIDIS; CAENORHABDITIS ELEGANS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DICTYOSTELLIUM DISCOIDEUM; DROSOPHILA MELANOGASTER; FUNGAL PATHOGENESIS; FUNGAL VIRULENCE; GALLERIA MELLONELLA; HEAT TOLERANCE; HISTOPLASMA CAPSULATUM; HOST SELECTION; INSECT; INVERTEBRATE; INVERTEBRATE MODEL HOST; MYCOSIS; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; SILKWORM; SPOROTHRIX SCHENCKII; TEMPERATURE SENSITIVITY; ZYGOMYCETES; ANIMAL; DISEASE MODEL; FUNGUS; HOST PATHOGEN INTERACTION; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

INVERTEBRATA;

ANIMALS; ANTIFUNGAL AGENTS; DISEASE MODELS, ANIMAL; FUNGI; HOST-PATHOGEN INTERACTIONS; INVERTEBRATES; PHAGOCYTOSIS; VIRULENCE;

EID: 84860906111     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002451     Document Type: Article

References (20)

1. Steenbergen JN, Shuman HA, Casadevall A, (2001) Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A 98: 15245-15250.
2. Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A, (2003) Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect Immun 71: 4862-4872.
3. Mylonakis E, Ausubel FM, Perfect JR, Heitman J, Calderwood SB, (2002) Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci U S A 99: 15675-15680.
4. Alarco AM, Marcil A, Chen J, Suter B, Thomas D, et al. (2004) Immune-deficient Drosophila melanogaster: a model for the innate immune response to human fungal pathogens. J Immunol 172: 5622-5628.
5. Brennan M, Thomas DY, Whiteway M, Kavanagh K, (2002) Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 34: 153-157.
6. Lionakis MS, Kontoyiannis DP, (2010) The growing promise of Toll-deficient Drosophila melanogaster as a model for studying Aspergillus pathogenesis and treatment. Virulence 1: 488-499.
7. Fuchs BB, O'Brien E, Khoury JB, Mylonakis E, (2010) Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 1: 475-482.
8. Hanaoka N, Takano Y, Shibuya K, Fugo H, Uehara Y, et al. (2008) Identification of the putative protein phosphatase gene PTC1 as a virulence-related gene using a silkworm model of Candida albicans infection. Eukaryot Cell 7: 1640-1648.
9. Laws TR, Smith SA, Smith MP, Harding SV, Atkins TP, et al. (2005) The nematode Panagrellus redivivus is susceptible to killing by human pathogens at 37 degrees C. FEMS Microbiol Lett 250: 77-83.
10. Fan W, Idnurm A, Breger J, Mylonakis E, Heitman J, (2007) Eca1, a sarcoplasmic/endoplasmic reticulum Ca2+-ATPase, is involved in stress tolerance and virulence in Cryptococcus neoformans. Infect Immun 75: 3394-3405.
11. Bergin D, Brennan M, Kavanagh K, (2003) Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes Infect 5: 1389-1395.
12. Noegel AA, Schleicher M, (2000) The actin cytoskeleton of Dictyostelium: a story told by mutants. J Cell Sci 113 (Pt 5): 759-766.
13. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, et al. (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3: e18.
14. Yanik MF, Rohde CB, Pardo-Martin C, (2011) Technologies for micromanipulating, imaging, and phenotyping small invertebrates and vertebrates. Annu Rev Biomed Eng 13: 185-217.
15. Vu K, Gelli A, (2010) Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii. Med Mycol 48: 255-262.
16. Chamilos G, Lewis RE, Kontoyiannis DP, (2006) Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother 50: 96-103.
17. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E, (2009) Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 8: 1750-1758.
18. Apidianakis Y, Rahme LG, Heitman J, Ausubel FM, Calderwood SB, et al. (2004) Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot Cell 3: 413-419.
19. Tang RJ, Breger J, Idnurm A, Gerik KJ, Lodge JK, et al. (2005) Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach. Infect Immun 73: 8219-8225.
20. Fuchs BB, Eby J, Nobile CJ, El Khoury JB, Mitchell AP, et al. (2010) Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect 12: 488-496.